A Requirement for p120-catenin in the metastasis of invasive ductal breast cancer

Author:

Kurley Sarah J.1ORCID,Tischler Verena2ORCID,Bierie Brian3ORCID,Novitskiy Sergey V.1,Noske Aurelia2ORCID,Varga Zsuzsanna2ORCID,Zürrer-Härdi Ursina2ORCID,Brandt Simone2ORCID,Carnahan Robert H.45ORCID,Cook Rebecca S.1,Muller William J.67ORCID,Richmond Ann15ORCID,Reynolds Albert B.15ORCID

Affiliation:

1. Department of Cancer Biology, Vanderbilt University, Nashville, TN, USA

2. Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland

3. Whitehead Institute for Biomedical Research, Cambridge, MA, USA

4. Department of Pediatrics, Vanderbilt University, Nashville, TN, USA

5. Vanderbilt-Ingram Cancer Center, Nashville, TN, USA

6. Goodman Cancer Centre, Montreal, Quebec, Canada

7. Departments of Biochemistry and Medicine, McGill University, Montreal, Quebec, Canada

Abstract

We have examined the effects of targeted p120 KO in a PyMT mouse model of invasive ductal (mammary) cancer (IDC). Mosaic p120 ablation had little effect on primary tumor growth but caused significant pro-metastatic alterations in the tumor microenvironment leading ultimately to a marked increase in the number and size of pulmonary metastases. Surprisingly, although early effects of p120-ablation included decreased cell-cell adhesion and increased invasiveness, cells lacking p120 were almost entirely unable to colonized distant metastatic sites in vivo. The relevance of this observation to human IDC was established by analysis of a large clinical dataset of 1126 IDCs. As reported by others, p120 downregulation in primary IDC predicted worse overall survival. However, as in the mice, distant metastases were almost invariably p120 positive, even in matched cases where the primary tumors were p120 negative. Collectively, our results demonstrate a strong positive role for p120 (and presumably E-cadherin) during metastatic colonization of distant sites. On the other hand, downregulation of p120 in the primary tumor enhanced metastatic dissemination indirectly via pro-metastatic conditioning of the tumor microenvironment.

Funder

National Institutes of Health

Susan G. Komen

Publisher

The Company of Biologists

Subject

Cell Biology

Reference68 articles.

1. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis;Andrechek;Proc. Natl. Acad. Sci. USA,2000

2. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth;Andrechek;Oncogene,2005

3. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers;Berx;EMBO J.,1995

4. [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics];Bocker;Verh. Dtsch. Ges. Pathol.,2002

5. EMT and MET in metastasis: where are the cancer stem cells?;Brabletz;Cancer Cell,2012

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3